Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Borst GR et al. - The authors derived a significant dose–response relationship between the risk of RP and the MLD for SBRT from the clinical data. This relation was not significantly different from the dose–response relation for CFRT, although statistical analysis was hampered by the low number of patients in the high dose range.